T. Miyai

Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases

N. Fujii, M. Kohzuki, O. Ito, 2019, Renal Replacement Therapy.

Individualized concept for the treatment of autosomal recessive polycystic kidney disease with end‐stage renal disease

M. Hattori, M. Okumi, M. Kasahara, 2020, Pediatric transplantation.

Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period.

Hiroyuki Tanaka, Y. Seino, T. Morishima, 2010, Bone.

New‐onset diabetes after renal transplantation in a patient with a novel HNF1B mutation

M. Hattori, K. Iijima, N. Sugawara, 2016, Pediatric transplantation.

Neonatal-Onset Hereditary Coproporphyria: A New Variant of Hereditary Coproporphyria.

H. Tsukahara, Hiroyuki Tanaka, K. Iwatsuki, 2017, JIMD reports.

Immunoglobulin resistance in Kawasaki disease with chronic granulomatous disease

T. Moriwake, M. Tsuge, T. Miyai, 2012, Pediatrics international : official journal of the Japan Pediatric Society.

Functional analysis of NPHS 1 mutations in Japanese 1 patients 2 3

K. Yan, Hiroyuki Tanaka, Y. Sado, 2013 .

Longitudinal analysis of Epstein–Barr virus‐associated illness

K. Chayama, T. Morishima, Hidehiko Maruyama, 2008, Pediatrics international : official journal of the Japan Pediatric Society.

Urinary Cross-linked N-terminal Telopeptide of Type I Collagen Levels of Infants with Osteogenesis Imperfecta and Healthy Infants.

H. Tsukahara, Hiroyuki Tanaka, A. Okada, 2016, Acta medica Okayama.